PH01000025G1180's details annotation
1.Annotation
ICBR annotation: peptidase, putative, expressed
Blast result AT5G43600 : 2.00E-179
Blast annotation: ureidoglycolate amidohydrolase
2.Location
Scaffold: PH01000025
Strand: -
| Region | Start | End |
| gene | 880957 | 886053 |
| mRNA | 880957 | 886053 |
| exon | 880957 | 881141 |
| exon | 881453 | 881493 |
| exon | 881700 | 881940 |
| exon | 882033 | 882095 |
| exon | 882604 | 882734 |
| exon | 882774 | 882876 |
| exon | 882947 | 883149 |
| exon | 884257 | 884385 |
| exon | 884902 | 884976 |
| exon | 885360 | 885445 |
| exon | 885596 | 886053 |
| CDS | 881044 | 881141 |
| CDS | 881453 | 881493 |
| CDS | 881700 | 881940 |
| CDS | 882033 | 882095 |
| CDS | 882604 | 882734 |
| CDS | 882774 | 882876 |
| CDS | 882947 | 883149 |
| CDS | 884257 | 884385 |
| CDS | 884902 | 884976 |
| CDS | 885360 | 885445 |
| CDS | 885596 | 885781 |
3.Network
| Co-expression Network Category | Global Network | Conditional Network | |
| Co-expression Positive |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Co-expression Negative |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Predict protein-portein interaction | null | ||
| miRNA-targets relationship | null | ||
4.Functional module
| Method | Module ID | Function Annotation |
| coexpression network | null | null |
5.Cis-elements
Details in 3kb promoter region
6.Expression profilings
7.Gene family
| Category | Family |
| null | null |
8.Protein domain
| Pfam Accession | Pfam Annotation | Alignment Start | Alignment Start |
| PF01546.27 | Peptidase_M20 | 128 | 461 |
9.KEGG Pathway
| Pathway | KEGG Ortholog | Pathway ID | KO |
| null | null | null | null |
10.Gene Ontology
| GO Accession | GO Annotation |
| GO:0008152 | metabolic process |
| GO:0016787 | hydrolase activity |
| GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines |
Maintained by Xuelian Ma - Zhen Su's Lab - China Agricultural University
© 2017 All Rights Reserved.
© 2017 All Rights Reserved.